7,822 press releases indexed under healthcare.
ATLANTA, Sept. 14, 2026 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of digital, engineering, and scientific solutions for health and defense missions, today announced that Brooke Pierce has been appointed President, Health, effective September 14, 2026.
Acquisition positions Veracyte to deliver powerful genomic insights from urine, tissue, and blood to help guide bladder cancer care across the patient journey Acquisition positions Veracyte to deliver powerful genomic insights from urine, tissue, and blood to help guide bladder cancer care across the patient journey
New York, New York--(Newsfile Corp. - September 14, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS) on behalf of investors that purchased or otherwise acquired Hims & Hers securities between August 4, 2025 and July 29, 2026 (the "Class Period").CLICK HERE TO JOIN THE CASEIf you are an investor in Hims & Hers and have suffered losses, you may CLICK HERE to contact us. You may...
(PR-inside.com) Prime Ledger engaged to structure an asset-specific, non-dilutive tokenized financing for CCX0722 - backed by intellectual property, with no issuance of Cosmos Health common stock Positions Cosmos Health among the earliest NASDAQ-listed healthcare companies pursuing tokenized IP-backed assets. CCX0722 is an ingestible, hydrogel-based medical device in development for weight management, using a mechanical mechanism with no systemic absorption Intellectual property owned outright, with patent applications advanced into the United States, Europe, Australia and Canada Addresses a global weight management market projected to reach $562.2 billion by 2033 (14.2% CAGR) - set against a broader tokenized real-world-asset market projected to reach ..
Endolumik, a medical device company developing fluorescence-guided surgical tools for minimally invasive procedures, today announced it has expanded the labeled use of its Endolumik Gastrointestinal Calibration Tube to include lower gastrointestinal tract surgical procedures, including colorectal surgery. Previously used in gastric and foregut procedures, the Endolumik device is designed to provide fluorescence-guided [PR.com]
Researchers across the field, from Duke University to Mayo Clinic, are increasingly focused on restoring damaged cartilage rather than simply managing the symptoms associated with its loss. Regentis Biomaterials’ GelrinC is designed to support the body’s natural cartilage-regeneration process through a gradual, controlled repair environment. Early clinical data has provided encouraging evidence for GelrinC, which already has approval in Europe, while an FDA-authorized pivotal trial is advancing its development toward potential U.S. approval. LOS ANGELES, CA - September 14, 2026 ( NEWMEDIAWIRE ) - A knee that once carried a runner through marathons or a hiker up a steep mountainside can be sidelined by a single defect in cartilage. More broadly, nearly a half-million Americans end up with k
NASA has selected 12 new investigations to help support human explorers in space. Six will help advance the ability to produce food off-planet, while another six advance the understanding of how unique conditions associated with space exploration can impact the health and physiology of astronauts. The six food-focused investigations, supported by the agency’s Space […]
AUSTIN, Texas, September 14, 2026--Paradromics Inc., a neurotechnology company developing a high-data-rate brain-computer interface (BCI) platform designed to restore and enhance human capabilities, today announced that the first participant implanted with the Connexus® BCI has successfully used the system for real-time speech and text communication. The milestone was achieved as part of the Connect-One Early Feasibility Study, conducted under an FDA-approved Investigational Device Exemption (ID
LOS ANGELES, September 14, 2026--Ammortal, the human optimization company focused on elevating potential through advanced technology and transcendent experience, today announced the expansion of its partnership with Next Health, the most advanced and comprehensive brand of health optimization and longevity centers, following the partnership’s introduction at Next Health’s annual summit. The Ammortal Chamber is now available at three Next Health locations, with plans to expand to additional locat
The national telepsychiatry practice appoints Kara Birch, DNP, PMHNP-BC, FNP-BC, and Anna Lau, MSN, PMHNP-BC, WHNP-BC, to strengthen clinical excellence and nursing operations. NEW YORK, Sept. 14, 2026 /PRNewswire/ -- As telepsychiatry expands access to mental health care, maintaining...
WOIPPY, France, September 14, 2026--Regulatory News: ABL Diagnostics (Euronext Paris: ABLD – ISIN: FR001400AHX6) (the "Company"), a company specializing in molecular diagnostic solutions, healthcare software and clinical research services, informs its shareholders and the broader financial community that the latest equity research report on the Company, prepared by All Invest Securities, is now available.
This acquisition expands Endpoint into clinical supply planning while keeping Bluefin independent and RTSM-agnostic. RALEIGH, N.C. and BOSTON, Sept. 14, 2026 /PRNewswire/ -- Endpoint Clinical L.P., a global leader in randomization and trial supply management ("RTSM") solutions and a...